Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_assertion type Assertion NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_head.
- NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_assertion description "[It has been shown that serum and CSF levels of PECAM-1 and sPECAM-1 are increased in patients in active stages of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_provenance.
- NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_assertion evidence source_evidence_literature NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_provenance.
- NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_assertion SIO_000772 17116209 NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_provenance.
- NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_assertion wasDerivedFrom befree-20150227 NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_provenance.
- NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_assertion wasGeneratedBy ECO_0000203 NP615361.RAtdufz4sQUfo9-dE9i7ExF3SeFw_4tl5eO8PkduaA6iI130_provenance.